A Phase I Study of Mozobil in the Treatment of Patients With WHIMS | MicrobiomeTrials← Back to trialsNCT00967785
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
RecruitingPHASE1, PHASE2INTERVENTIONAL
Trial Details
Start: 2010-01-06Est. Completion: 2026-12-31
Enrollment target: 20 participants Locations- National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Other microbiome trials you might be interested in
Hematologic Disease and DisordersDonorsHealthy Volunteer
This study allows the evaluation of subjects in order to determine their ability to safely participate in other active r…
Bethesda, United States
Idiopathic CD4+ LymphocytopeniaCryptococcal MeningitisWarts
Background:
* Idiopathic CD4+ lymphocytopenia (ICL) is a condition in which there is a decreased level of CD4+ lymphocy…
Bethesda, United States